Celularity, a biotech company specializing in placental-derived allogeneic cell therapies, will be showcasing data at the ...

CN Bio has raised $21 million in Series B financing to meet increasing demand for its organ-on-a-chip (OOC) solutions.

Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) version of Entyvio, ...

At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of ...

After two major acquisitions, Biosynth is coming to CPHI North America ready to tell the industry about its enhanced ...

What is ADC specialist Piramal Pharma planning for the upcoming CPHI North America conference? We sat down with chief ...

According to data and analytics firm GlobalData, the burden of hospitalized incident cases of methicillin-resistant ...

Torbay Pharmaceuticals is a sterile injectable contract manufacturer and licence holder based in Devon, UK. We spoke with CEO ...

SynOx Therapeutics has raised $75m in Series B financing, co-led by Forbion, HealthCap and new investor Bioqube Ventures.

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at ...

SK pharmteco has signed an agreement with Ferring Pharmaceuticals, to scale up commercial manufacturing capacity for the drug ...

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and ...